文献速递生殖医学妇科

多囊卵巢综合征与不明原因不孕女性的性功能

Sexual function in infertile women with polycystic ovary syndrome and unexplained infertility.
PubMed 文献 · Am J Obstet Gynecol · 2017-04-26

该研究对两项临床试验数据行二次分析,用女性性功能量表与女性性困扰量表评估多囊卵巢综合征与不明原因不孕女性的性功能。两组性功能评分几乎相同,多囊卵巢综合征组性困扰总分更高;游离雄激素指数升高时性功能总分轻度升高,主要来自性欲维度。

要点

  • 多囊卵巢综合征与不明原因不孕女性性功能评分几乎相同。
  • 多囊卵巢综合征组女性性困扰量表总分更高。
  • 游离雄激素指数升高时性功能总分轻度升高,主要来自性欲维度。

核心结论

  • 育龄期多囊卵巢综合征相关不孕与不明原因不孕女性,尽管雄激素表现存在表型与生化差异,性功能无临床显著差异。

研究设计与样本

  • 对2项美国国立儿童健康与人类发育研究所合作生殖医学网络临床试验行二次数据分析:多囊卵巢综合征妊娠研究II与卵巢刺激多胎妊娠评估研究。
  • 两项方案均用女性性功能量表与女性性困扰量表评估女性性功能。

主要发现

  • 多囊卵巢综合征组体重与体质指数高于不明原因不孕组(各P < .001)。
  • 多囊卵巢综合征组表型雄激素过多证据更强:Ferriman-Gallwey多毛评分、皮脂评分与痤疮评分均更高(各P < .001)。
  • 多囊卵巢综合征组生化雄激素过多证据更强:睾酮、游离睾酮与脱氢表雄酮均更高(各P < .001)。
  • 女性性功能量表评分两组几乎相同;女性性困扰量表总分多囊卵巢综合征组更高。
  • 游离雄激素指数升高时女性性功能量表总分轻度升高,主要来自性欲维度,该关联在不明原因不孕组更明显。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: While female sexual dysfunction is a frequent occurrence, characteristics in infertile women are not well delineated. Furthermore, the impact of infertility etiology on the characteristics in women with differing androgen levels observed in women with polycystic ovary syndrome and unexplained infertility has not been assessed. OBJECTIVE: The objective of the study was to determine the characteristics of sexual dysfunction in women with polycystic ovary syndrome and unexplained infertility. STUDY DESIGN: A secondary data analysis was performed on 2 of Eunice Kennedy Shriver National Institute of Child Health and Human Development Cooperative Reproductive Medicine Networks clinical trials: Pregnancy in Polycystic Ovary Syndrome Study II and Assessment of Multiple Intrauterine Gestations From Ovarian Stimulation. Both protocols assessed female sexual function using the Female Sexual Function Inventory and the Female Sexual Distress Scale. RESULTS: Women with polycystic ovary syndrome had higher weight and body mass index than women with unexplained infertility (each P < .001), greater phenotypic (Ferriman-Gallwey hirsutism score, sebum score, and acne score; each P < .001), and hormonal (testosterone, free testosterone, and dehydroepiandrosterone; each P < .001) evidence of androgen excess. Sexual function scores, as assessed by the Female Sexual Function Inventory, were nearly identical. The Female Sexual Distress Scale total score was higher in women with polycystic ovary syndrome. The mean Female Sexual Function Inventory total score increased slightly as the free androgen index increased, mainly as a result of the desire subscore. This association was more pronounced in the women with unexplained infertility. CONCLUSION: Reproductive-age women with infertility associated with polycystic ovary syndrome and unexplained infertility, despite phenotypic and biochemical differences in androgenic manifestations, do not manifest clinically significant differences in sexual function.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Diamond MP, Legro RS, Coutifaris C, et al. Sexual function in infertile women with polycystic ovary syndrome and unexplained infertility. Am J Obstet Gynecol. 2017. PMID: 28455078. doi:10.1016/j.ajog.2017.04.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。